In terms of a diagnostics approach, the imprecise definitions of symptoms for the clinical diagnosis of EA2 and the large number of exons in the CACNA1A gene, make obtaining a clear clinical diagnosis using direct genetic testing using conventional Sanger sequencing for molecular diagnosis extremely difficult. Here, CACNA1A is linked to episodic ataxia type 2.